As health care costs continue to rise, artificial intelligence (AI)-driven solutions are emerging as a powerful tool for ...

Caspian Oliai, MD, MS, medical director of the UCLA Bone Marrow Transplantation Stem Cell Processing Center, discusses ...

Patient-reported outcomes measures in generalized myasthenia gravis (gMG) are more important than ever, for both those ...

Mobile self-management programs like that offered by Hello Heart can benefit employers and patients alike as they seek to ...

Federal legislative and regulatory changes are reshaping pharmacy practice, with key challenges in government funding, ...

After fine-tuning, the VGG16 convolutional neural network outperformed other deep learning models in 2 of 3 key ...

Social determinants of health been long understood to influence health outcomes, and this new analysis explores more deeply ...

The Inflation Reduction Act (IRA) may be restricting Medicare Part D formularies, increasing patient costs, and stifling ...

Adam Colborn, JD, vice president for congressional affairs, AMCP, discusses key regulatory factors that managed care professionals must consider when implementing artificial intelligence (AI) in ...

Neha Kashalikar, PharmD, director of strategic pharmacy consulting, MassHealth, shares key components that makes a value-based contract successful.

Prior authorizations create substantial administrative and financial burdens on physicians and patients and can disrupt the continuity of care.

Janus kinase (JAK) inhibitors, including ruxolitinib cream and abrocitinib, demonstrate strong efficacy in atopic dermatitis ...